NVIDIA's supply chain risks - CEO explains | Jensen Huang and Lex Fridman
Jensen Huang discusses how NVIDIA proactively manages its complex supply chain by directly engaging hundreds of CEOs to communicate future demand and coordinate massive investments. Rather than losing sleep over supply chain risks, he focuses on building relationships and ensuring suppliers understand NVIDIA's roadmap to enable proper planning.
Summary
Jensen Huang addresses the complexity of managing NVIDIA's supply chain during unprecedented growth, emphasizing that no company in history has grown at their scale while continuing to accelerate. He describes his hands-on approach of regularly communicating with hundreds of CEOs across the entire IT and infrastructure industries, both upstream suppliers and downstream customers. Huang explains how he proactively educates these partners about NVIDIA's business conditions, growth drivers, and future direction to help them make informed investment decisions. He provides specific examples of successfully convincing memory manufacturers to invest in HBM memory and LPDDR5 for data centers, despite initial skepticism about using these technologies outside their traditional applications. The conversation reveals how NVIDIA's architectural shift from DGX-1 to MVLink-72 required fundamental changes in manufacturing approach, moving supercomputer integration from data centers into the supply chain itself. Each rack now contains 1.3-1.5 million components from 200 suppliers, requiring suppliers to significantly increase their power capacity for building and testing. Huang describes his process of flying to meet partners personally, explaining the technical and business rationale through first principles reasoning, and requesting billions in capital investments from each supplier. When asked about specific bottlenecks like ASML's EUV lithography or TSMC's advanced packaging, Huang expresses confidence rather than worry, stating that clear communication of needs and mutual understanding with suppliers allows him to trust their execution.
About this episode
Lex Fridman Podcast full episode: https://www.youtube.com/watch?v=vif8NQcjVf0 Thank you for listening ❤ Check out our sponsors: https://lexfridman.com/sponsors/cv9763-sb See below for guest bio, links, and to give feedback, submit questions, contact Lex, etc. *GUEST BIO:* Jensen Huang is the co-founder and CEO of NVIDIA, the world's most valuable company and the engine powering the AI computing revolution. *CONTACT LEX:* *Feedback* - give feedback to Lex: https://lexfridman.com/survey *AMA* - submit questions, videos or call-in: https://lexfridman.com/ama *Hiring* - join our team: https://lexfridman.com/hiring *Other* - other ways to get in touch: https://lexfridman.com/contact *EPISODE LINKS:* NVIDIA: https://nvidia.com NVIDIA on X: https://x.com/nvidia NVIDIA AI on X: https://x.com/NVIDIAAI NVIDIA on YouTube: https://youtube.com/@NVIDIA NVIDIA on Instagram: https://www.instagram.com/nvidia/ NVIDIA on LinkedIn: https://www.linkedin.com/company/nvidia/ NVIDIA on Facebook: https://www.facebook.com/NVIDIA/ NVIDIA on GitHub: https://github.com/NVIDIA Nemotron: https://developer.nvidia.com/nemotron *SPONSORS:* To support this podcast, check out our sponsors & get discounts: *Perplexity:* AI-powered answer engine. Go to https://lexfridman.com/s/perplexity-cv9763-sb *Shopify:* Sell stuff online. Go to https://lexfridman.com/s/shopify-cv9763-sb *LMNT:* Zero-sugar electrolyte drink mix. Go to https://lexfridman.com/s/lmnt-cv9763-sb *Fin:* AI agent for customer service. Go to https://lexfridman.com/s/fin-cv9763-sb *Quo:* Phone system (calls, texts, contacts) for businesses. Go to https://lexfridman.com/s/quo-cv9763-sb *PODCAST LINKS:* - Podcast Website: https://lexfridman.com/podcast - Apple Podcasts: https://apple.co/2lwqZIr - Spotify: https://spoti.fi/2nEwCF8 - RSS: https://lexfridman.com/feed/podcast/ - Podcast Playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 - Clips Channel: https://www.youtube.com/lexclips *SOCIAL LINKS:* - X: https://x.com/lexfridman - Instagram: https://instagram.com/lexfridman - TikTok: https://tiktok.com/@lexfridman - LinkedIn: https://linkedin.com/in/lexfridman - Facebook: https://facebook.com/lexfridman - Patreon: https://patreon.com/lexfridman - Telegram: https://t.me/lexfridman - Reddit: https://reddit.com/r/lexfridman
Key Insights
- Moving from reactive supply chain management to proactive future-shaping: Rather than waiting for bottlenecks to emerge, successful scaling requires actively educating suppliers about future demand patterns and technology shifts 2-3 years in advance to enable proper capacity planning
- Transforming manufacturing location and integration strategies can solve scalability problems: NVIDIA moved supercomputer assembly from data centers into the supply chain itself, enabling higher density systems but requiring suppliers to dramatically increase their power infrastructure for testing
Topics
Transcript
How much does it keep you up at night? The bottlenecks in the supply chain of AI, like ASML with EUV lithography machines, GSMC with advanced packaging, like CoaS, and SK Hynix with high bandwidth memory. All the time. And we're working on it all the time. No company in history has ever grown at a scale that we're growing while accelerating that growth. It's incredible. And it's hard for people to even understand this. In the overall world of AI computing, we're increasing share. And so supply chain, upstream and downstream, are really important to us. I spend a lot of time informing all the CEOs that I work with, what are the dynamics that's going to cause the…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Lex Clips
Do antipsychotic drugs work? | Andrew Scull and Lex Fridman
Andrew Scull discusses the efficacy and serious side effects of antipsychotic drugs, explaining that while they help some patients, many are non-responders, and the medications carry substantial risks including tardive dyskinesia, weight gain, metabolic syndrome, and cognitive dulling. The landmark CATIE study revealed that newer, expensive second-generation antipsychotics are no more effective than older first-generation drugs, with 67-82% of patients dropping out due to inefficacy or intolerable side effects.
Surprising origin of antipsychotic drugs | Andrew Scull and Lex Fridman
Andrew Scull explains how chlorpromazine, an antihistamine synthesized in the 1880s, was accidentally discovered to have psychiatric applications in the 1950s through French Navy lieutenant Alain Laborit's experiments. The drug's rapid adoption was driven by pharmaceutical companies' aggressive marketing to politicians and hospital administrators rather than by psychiatrists' initial enthusiasm, transforming it from a 'major tranquilizer' into the first 'antipsychotic' drug.
Cognitive Behavioral Therapy (CBT) vs Psychoanalysis | Andrew Scull and Lex Fridman
Andrew Scull discusses how clinical psychology and cognitive behavioral therapy (CBT) emerged after WWII as alternatives to psychoanalysis, becoming dominant through better empirical evidence, shorter treatment duration, and federal funding advantages. CBT's symptom-focused approach proved more measurable and reproducible than psychoanalytic theory, though its effectiveness remains limited for serious mental disorders.
Do anti-depressant drugs work? | Andrew Scull and Lex Fridman
Andrew Scull discusses the history and efficacy of antidepressants, particularly SSRIs like Prozac, explaining that while they statistically outperform placebo, the clinical improvement is often marginal and comes with significant side effects including sexual dysfunction and withdrawal difficulties. He also addresses 'diagnostic creep' in psychiatry, where conditions become increasingly broadly defined and diagnosed over time.
How drugs and psycho-pharmacology changed mental health | Andrew Scull and Lex Fridman
Andrew Scull traces the accidental discovery of psychopharmacology, beginning with chlorpromazine's unexpected psychiatric effects in the 1950s, and discusses how pharmaceutical companies transformed mental health treatment while also introducing serious side effects like tardive dyskinesia and metabolic complications that remain inadequately addressed.